Fingerprint
Dive into the research topics of 'Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome
Soma Jyonouchi, Brenda Gwafila, Lavesh A. Gwalani, Maria Ahmad, Chistopher Moertel, Cecil Holbert, Ji Young Kim, Nathan Kobrinsky, Sumita Roy-Ghanta, Jordan S. Orange
Research output: Contribution to journal › Article › peer-review
27
Scopus
citations